Sub-Saharan African countries continue to struggle with chronic, year-round blood shortages, limiting their ability to support patients and deliver on the health-related Sustainable Development Goals (SDGs).
Hemoclear joins forces with VDL HemoClear joins forces with VDL in manufacturing the HemoClear autologous blood filter. The Dutch innovation HemoClear is the first blood filter that allows patients shed …
In the strategic ambition to optimize production, increase flexibility, and decrease lead times and costs, HemoClear will centralize all production activities in the Netherlands. As a promising kick-off of …
As a proud sponsor, HemoClear attended the Bloodless Medicine and Surgery Society Annual Meeting. At the event Dr Rosita Bihariesingh presented a case of severe bleeding after surgery, HemoClear provided …
After celebrating Bloodless Medicine and Surgery Day on May 16, HemoClear is attending the Annual Bloodless Medicine and Surgery Week Conference. On Thursday Dr James Amenge will present ‘’Comparing Cell …
78% mortality reduction in ICU-admitted COVID-19 patients in Suriname after treatment with convalescent plasma (CP) obtained by the HemoClear blood filter. Clinical trial An open-label, multi-center, prospective clinical trial was …
HemoClear B.V. received CE Mark approval for its first-in-class, technology, the HemoClearTM autologous blood filter
As a proud sponsor, HemoClear is attending the 28th Nigerian Society of Anaesthetists Annual Scientific Conference. Dr Rosita Bihariesingh has been at the frontline of the coronavirus pandemic in Suriname. …
HemoClear attends the Bloodless Medicine & Surgery Society 2020 Annual Scientific Conference. Our Chief Medical Officer, Dr Arno Nierich, will present the HemoClear device as a gamechanger in the field …
COVID-19 plasma donatie geeft vroeg in het genezingsproces een hogere opbrengst van antistoffen dan later in dat proces. https://www.rtvoost.nl/nieuws/1271486/Bloedplasma-doneren-in-ziekenhuizen-biedt-snellere-genezing-coronapatienten
